No definition available.
Brain glioblastoma, excluding all cancers (controls excluding all cancers)
C3_GBM_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditions
|
435 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
435 |
4. Check minimum number of eventsNone |
435 |
5. Include endpoints |
435 |
6. Filter based on genotype QC (FinnGen only) |
435 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
- Control conditions
- not HLP_C3_GBM
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Brain glioblastoma, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Brain glioblastoma
- Brain glioblastoma and astrocytoma
- Brain glioblastoma and astrocytoma, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of brain
- Malignant neoplasm of eye, brain and central nervous system
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 435 | 177 | 258 |
| Unadjusted period prevalence (%) | 0.09 | 0.06 | 0.11 |
| Median age at first event (years) | 65.80 | 66.18 | 65.54 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 411
- Matched controls
- 4109
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
1593.3
323.0
313
8
L01AX03
ATC
temozolomide; systemic
+∞
323.0
273
*
H02AB02
ATC
dexamethasone; systemic
1757.5
323.0
362
17
130
Kela drug reimbursment
Malignant tumour
+∞
323.0
311
*
N03AX14
ATC
levetiracetam; systemic
122.8
198.7
205
33
WF002
NOMESCO Finland
Radical radiotherapy
2749.2
185.0
165
*
A04AA02
ATC
granisetron; systemic, transdermal
1335.6
180.6
163
*
C71.23
ICD-10 Finland
Malignant tumor of temporal lobe grade IV glioma
+∞
163.8
146
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
38.9
158.6
207
104
Z51.5
ICD-10 Finland
Palliative care
117.6
157.3
164
23
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
557.1
154.2
144
*
A03FA01
ATC
metoclopramide; systemic, rectal
23.8
153.2
246
242
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
136.4
145.1
149
17
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
39.0
143.8
186
85
WF003
NOMESCO Finland
Adjuvant radiotherapy
940.1
140.6
130
*
9440/3-C71.9
ICD-O-3
Glioblastoma, NOS, of brain, NOS
+∞
139.8
126
*
C71.13
ICD-10 Finland
Malignant tumor of frontal lobe grade IV glioma
+∞
130.3
118
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
119.8
109
*
9440/3-C71.2
ICD-O-3
Glioblastoma, NOS, of temporal lobe
+∞
111.7
102
*
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
+∞
105.9
97
*
C71.90
ICD-10 Finland
Malignant tumor in unspecified localization in the brain without histology
+∞
104.8
96
*
C71.20
ICD-10 Finland
Malignant tumor in temporal lobe without histology
+∞
103.6
95
*
ZXC95
NOMESCO Finland
Use of surgical navigator
190.4
100.3
101
7
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
95.6
88
*
9440/3-C71.1
ICD-O-3
Glioblastoma, NOS, of frontal lobe
+∞
93.4
86
*
XX3DW
NOMESCO Finland
Time consuming IT work
22.0
91.3
139
93
C71.2
ICD-10 Finland
Malignant neoplasm: Temporal lobe
+∞
85.4
79
*
A04AA01
ATC
ondansetron; systemic, rectal
51.0
84.4
101
26
C71.10
ICD-10 Finland
Malignant tumor in frontal lobe without histology
+∞
80.9
75
*
C71.33
ICD-10 Finland
Malignant tumor of parietal lobe grade IV glioma
+∞
80.9
75
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
200.9
80.3
81
5
C71.1
ICD-10 Finland
Malignant neoplasm: Frontal lobe
+∞
79.8
74
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
33.0
71.9
95
37
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
210.1
69.4
70
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
68.7
64
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
766.5
68.0
65
*
AAG00
NOMESCO Finland
Stereotactic intracranial biopsy
+∞
64.3
60
*
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
247.1
63.0
63
*
AA1AD
NOMESCO Finland
CT of head and brain
6.1
58.9
215
630
C71.30
ICD-10 Finland
Malignant tumor in parietal lobe without histology
+∞
58.8
55
*
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
13.9
55.5
100
93
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
6.7
53.3
160
355
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
202.1
52.2
53
*
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
33.7
52.1
68
24
9440/3-C71.3
ICD-O-3
Glioblastoma, NOS, of parietal lobe
+∞
50.0
47
*
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
25.0
50.0
71
34
N02AA05
ATC
oxycodone; systemic
8.1
48.5
121
202
ZX050
NOMESCO Finland
Stereotactic radiotherapy
+∞
47.8
45
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
5.2
47.4
192
596
N03AX18
ATC
lacosamide; systemic
92.5
45.0
49
6
D43.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified
172.0
44.8
46
*
C71.3
ICD-10 Finland
Malignant neoplasm: Parietal lobe
+∞
44.6
42
*
C71.83
ICD-10 Finland
Overall malignant tumor of the brain grade IV glioma
+∞
42.4
40
*
N74
ICPC
Malignant neoplasm nervous system
450.5
41.9
41
*
D43.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, unspecified
+∞
41.3
39
*
WX882
NOMESCO Finland
High dependency care
16.4
37.9
62
44
ZXM40
NOMESCO Finland
Use of fluorescent substance
401.7
37.6
37
*
WZC30
NOMESCO Finland
Teaching
6.7
37.6
105
199
C71.99
ICD-10 Finland
Malignant tumor in unspecified localization in the brain other or unspecified histology
+∞
37.0
35
*
ZXC40
NOMESCO Finland
Use of ultrasound
88.5
36.5
40
5
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
377.7
35.5
35
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
377.7
35.5
35
*
A02BC02
ATC
pantoprazole; systemic
4.1
33.9
325
1980
WX402
NOMESCO Finland
General anaesthesia
5.4
33.8
114
271
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
6.8
33.6
92
168
N03AF02
ATC
oxcarbazepine; oral
13.6
32.9
58
49
AA1BD
NOMESCO Finland
Extensive CT of head and brain
18.6
31.0
48
29
N05CD08
ATC
midazolam; nasal, systemic
16.4
29.1
47
32
A28
ICPC
Limited function/disability NOS
4.6
28.7
115
323
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
28.5
27
*
C71.93
ICD-10 Finland
Malignant tumor in an unspecified localization in the brain grade IV glioma
+∞
27.4
26
*
R56.8
ICD-10 Finland
Other and unspecified convulsions
8.0
27.0
64
93
JN4BD
NOMESCO Finland
Extensive body CT
8.0
26.4
62
89
C71.29
ICD-10 Finland
Malignant tumor in temporal lobe other or unspecified histology
+∞
26.3
25
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
77.6
26.1
29
*
WF004
NOMESCO Finland
Palliative radiotherapy
277.0
26.0
26
*
A79
ICPC
Malignancy NOS
132.7
23.9
25
*
C71.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of brain
+∞
22.1
21
*
C71.43
ICD-10 Finland
Malignant tumor of the occipital lobe grade IV glioma
+∞
22.1
21
*
G40.9
ICD-10 Finland
Epilepsy, unspecified
10.1
21.9
44
48
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
18.8
21.7
33
19
A98
ICPC
Health maint/preventive medicine
0.3
21.1
268
3509
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.6
20.9
110
380
TPH04
NOMESCO Finland
Cathetrisation of vein
3.3
20.7
123
467
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.6
20.5
106
362
C71.00
ICD-10 Finland
Malignant tumor of the cerebrum except lobes and ventricles without histology
+∞
19.9
19
*
9440/3-C71.0
ICD-O-3
Glioblastoma, NOS, of cerebrum
+∞
19.9
19
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
19.9
19
*
B01AB10
ATC
tinzaparin; parenteral
7.2
19.7
49
76
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
11.5
19.3
36
34
N05CF01
ATC
zopiclone; oral
2.7
19.1
173
863
C71.03
ICD-10 Finland
Malignant tumor of cerebellum except lobes and ventricles grade IV glioma
+∞
18.9
18
*
AAA10
NOMESCO Finland
Biopsy through craniotomy
+∞
17.8
17
*
C71.40
ICD-10 Finland
Malignant tumor of the occipital lobe without histology
+∞
17.8
17
*
C71.80
ICD-10 Finland
Overall malignant tumor of the brain without histology
+∞
17.8
17
*
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
22.1
17.5
25
12
WX408
NOMESCO Finland
General anesthesy, balanced
2.9
17.4
131
576
WX872
NOMESCO Finland
Intensive care
5.2
17.0
54
115
D43.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, infratentorial
+∞
16.8
16
*
C71.9
ICD-10 Finland
Malignant neoplasm: Brain, unspecified
+∞
16.8
16
*
C71.19
ICD-10 Finland
Malignant tumor of frontal lobe other or unspecified histology
+∞
16.8
16
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
176.8
16.6
17
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
15.7
15
*
C71.22
ICD-10 Finland
Malignant tumor of temporal lobe grade III glioma
+∞
15.7
15
*
G41.9
ICD-10 Finland
Status epilepticus, unspecified
29.9
15.3
20
7
9440/3-C71.8
ICD-O-3
Glioblastoma, NOS, of overlapping lesion of brain
+∞
14.7
14
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
14.7
14
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
155.2
14.6
15
*
XA800
NOMESCO Finland
Neuropsychological investigation
6.1
14.0
38
67
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
35.3
13.6
17
5
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
19.0
13.5
20
11
H53.4
ICD-10 Finland
Visual field defects
8.1
13.1
29
38
N03AB02
ATC
phenytoin; systemic
9.5
12.9
26
29
N76
ICPC
Neoplasm nervous system unspecified
72.1
12.7
14
*
G40.10
ICD-10 Finland
Simple partial seizures
33.2
12.7
16
5
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
33.2
12.7
16
5
TPH07
NOMESCO Finland
Cathetrisation of artery
3.9
12.6
54
155
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
+∞
12.6
12
*
115
Kela drug reimbursment
Breast cancer
+∞
12.6
12
*
9440/3-C71.4
ICD-O-3
Glioblastoma, NOS, of occipital lobe
+∞
12.6
12
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
8.9
12.5
26
31
R4120
NOMESCO Finland
Occupational therapy
4.0
12.4
50
136
JN4AD
NOMESCO Finland
Body CT examination
6.0
12.4
34
61
R4110
NOMESCO Finland
Physiotherapy
2.4
12.0
122
614
WX704
NOMESCO Finland
Intubation
4.0
12.0
48
130
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
15.2
11.9
19
13
C71.21
ICD-10 Finland
Malignant tumor of temporal lobe grade II glioma
+∞
11.5
11
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
11.5
11
*
R90.0
ICD-10 Finland
Intracranial space-occupying lesion
123.3
11.5
12
*
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
44.6
11.0
13
*
N05BA09
ATC
clobazam; oral
28.9
10.8
14
5
WX110
NOMESCO Finland
Local anesthesy
2.0
10.7
271
1997
C71.4
ICD-10 Finland
Malignant neoplasm: Occipital lobe
+∞
10.5
10
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
10.5
10
*
C71.39
ICD-10 Finland
Malignant tumor of parietal lobe other or unspecified histology
+∞
10.5
10
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
10.5
10
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
+∞
10.5
10
*
WX725
NOMESCO Finland
Noninvasive ventilation
5.0
10.2
32
68
N03AG01
ATC
valproic acid; systemic, rectal
4.0
9.7
38
101
N05BA04
ATC
oxazepam; oral
2.2
9.7
112
593
C71.01
ICD-10 Finland
Malignant tumor of cerebellum except lobes and ventricles grade II glioma
+∞
9.4
9
*
C71.32
ICD-10 Finland
Malignant tumor of parietal lobe grade III glioma
+∞
9.4
9
*
C71.12
ICD-10 Finland
Malignant tumor of frontal lobe grade III glioma
+∞
9.4
9
*
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
+∞
9.4
9
*
XF400
NOMESCO Finland
ECG with 12 standard connections
2.4
9.2
85
404
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
12.9
8.9
15
12
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
3.4
8.8
42
133
B01AB05
ATC
enoxaparin; parenteral
2.1
8.7
116
650
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
4.3
8.7
31
76
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.9
8.5
53
202
TKC20
NOMESCO Finland
Catheterisation of bladder
3.3
8.4
42
137
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
8.4
8
*
G93.6
ICD-10 Finland
Cerebral oedema
+∞
8.4
8
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
8.4
8
*
R41.0
ICD-10 Finland
Disorientation, unspecified
5.7
8.1
22
40
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
0.4
7.9
27
674
ZXM20
NOMESCO Finland
Intraoperative use of computerised tomography
25.5
7.6
10
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.2
7.6
38
125
L02BA01
ATC
tamoxifen; oral
81.5
7.4
8
*
N03AX23
ATC
brivaracetam; systemic
81.5
7.4
8
*
SPAT1245
SPAT
Provision of support and information to patient’s family members
4.0
7.3
28
74
G41.2
ICD-10 Finland
Complex partial status epilepticus
+∞
7.3
7
*
C71
ICD-10 Finland
Malignant neoplasm of brain
+∞
7.3
7
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
7.3
7
*
C71.0
ICD-10 Finland
Malignant neoplasm: Cerebrum, except lobes and ventricles
+∞
7.3
7
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
7.3
7
*
205
Kela drug reimbursment
Chronic hypertension
0.4
7.2
44
882
WX892
NOMESCO Finland
Monitored bed care
2.9
7.2
42
154
HAB40
NOMESCO Finland
Wedge excision of mammary gland
20.4
7.2
10
5
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
7.2
7.1
16
23
R51.80
ICD-10 Finland
Headache
2.5
7.0
56
244
H02AB09
ATC
hydrocortisone; systemic
5.8
6.8
18
32
YX8AD
NOMESCO Finland
Stereotactic CT examination for dose design of radiotherapy
40.7
6.8
8
*
ZSA00
NOMESCO Finland
Procedure related to previous procedure classified in chapter A
17.0
6.8
10
6
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
0.5
6.6
44
855
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
0.4
6.6
22
556
XA400
NOMESCO Finland
EEG
11.3
6.3
11
10
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
0.1
6.3
*
255
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
6.3
6
*
C71.50
ICD-10 Finland
Malignant tumor of cerebral ventricle without histology
+∞
6.3
6
*
1CD02
NOMESCO Finland
NA
+∞
6.3
6
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
6.3
6
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
6.3
6
*
G40.11
ICD-10 Finland
Simple partial epileptic seizure that develops into a complex partial seizure
27.1
6.2
8
*
D69.5
ICD-10 Finland
Secondary thrombocytopenia
27.1
6.2
8
*
C01DA14
ATC
isosorbide mononitrate; oral
0.3
6.2
15
439
R47.0
ICD-10 Finland
Dysphasia and aphasia
8.8
6.1
12
14
SAA02
NOMESCO Finland
Basic examination of mouth
0.6
6.1
130
1813
M75.1
ICD-10 Finland
Rotator cuff syndrome
0.4
6.1
29
637
AA5BD
NOMESCO Finland
CT of cerebral ischaemia
5.3
6.1
17
33
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
4.7
6.1
19
42
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
5.7
6.0
16
29
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
252
97
60.38
307.65
1.3
1.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
117
21
75.85
213.46
1.8
3.3
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
99
0
+∞
107.91
1.1
0.0
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
126
165
10.34
95.73
3.5
8.9
mmol/l
24.2
25.1
2.77
126
152
(3018677) aPTT in Platelet poor plasma by Coagulation assay
216
541
6.94
90.12
1.9
1.8
s
26.6
29.6
9.28
207
523
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
181
387
7.30
88.56
4.5
6.8
kpa
4.8
5.2
5.69
176
372
(3027801) Oxygen [Partial pressure] in Arterial blood
181
387
7.30
88.56
4.5
6.8
kpa
18.1
11.7
20.88
176
374
(3003396) Base excess in Arterial blood by calculation
181
388
7.28
88.31
4.5
6.8
mmol/l
0.9
1.6
2.45
133
303
(40768804) Tissue Pathology biopsy report
264
997
5.19
64.03
3.2
1.6
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
235
913
4.42
52.28
2.1
2.0
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
191
712
4.00
43.40
1.9
2.0
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
237
3578
0.26
41.84
3.0
4.8
mmol/l
4.9
4.6
2.55
210
3304
(42870588) Differential panel, method unspecified - Blood
236
1043
3.76
41.09
9.5
5.6
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
249
3643
0.26
40.60
3.2
5.4
mmol/l
3.0
2.7
3.11
219
3357
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
39
32
13.29
39.80
1.7
1.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
237
3550
0.27
39.15
3.0
4.8
mmol/l
1.4
1.4
0.07
212
3266
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
27
15
19.13
33.66
1.7
1.1
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
308
1761
3.57
33.09
18.7
6.5
e9/l
4.9
4.3
3.88
278
1531
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
228
3397
0.31
31.70
4.0
6.2
mmol/mol
40.4
40.2
0.08
211
3146
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
270
1454
3.26
31.47
5.5
5.0
mmol/l
1.2
1.2
4.88
264
1295
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
247
3519
0.31
30.65
4.1
4.8
mmol/l
6.2
6.0
0.45
216
3205
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
262
1403
3.18
30.52
3.2
3.5
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
25
15
17.62
30.00
1.6
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
44
63
7.66
29.81
1.9
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
237
3435
0.32
29.70
2.9
4.3
mmol/l
1.3
1.3
0.21
213
3144
(3016018) Differential panel - Cerebral spinal fluid
31
28
11.84
29.65
1.8
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
24
14
18.09
29.16
1.5
1.2
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
265
1474
3.04
28.02
9.9
5.5
%
1.3
3.0
33.87
260
1357
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
278
1593
3.06
27.75
6.4
5.5
mmol/l
1.2
1.2
2.35
251
1375
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
22
13
17.77
26.51
1.3
2.0
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
270
1582
2.86
24.80
9.9
5.3
e9/l
0.5
0.6
4.47
242
1368
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
22
15
15.39
24.66
1.3
1.8
%
16.5
13.3
—
10
6
(3006315) Basophils [#/volume] in Blood
270
1591
2.84
24.37
9.9
5.4
e9/l
0.0
0.0
17.53
241
1382
(3003694) ABO and Rh group [Type] in Blood
168
780
2.88
23.97
1.2
1.3
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
270
1606
2.80
23.67
10.1
5.4
e9/l
1.3
1.9
25.07
246
1412
(3013115) Eosinophils [#/volume] in Blood
274
1647
2.79
23.44
10.6
5.5
e9/l
0.1
0.2
41.41
242
1451
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
42
76
6.01
22.72
1.9
1.1
e6/l
48.1
5.6
0.86
36
62
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
42
76
6.01
22.72
2.0
1.2
e6/l
5152.8
1526.4
0.46
36
63
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
43
85
5.50
21.18
1.6
1.2
mg/l
966.5
447.2
1.95
43
80
(3032080) INR in Blood by Coagulation assay
234
1357
2.57
20.62
5.6
8.6
inr
1.1
1.3
2.87
65
366
(3023410) Appearance of Cerebral spinal fluid
27
34
8.40
20.23
2.2
1.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
169
858
2.59
19.46
3.2
3.9
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
188
1023
2.48
18.46
10.1
2.1
mmol/l
2.3
2.4
0.10
178
839
(40758558) Short blood count panel - Blood
148
721
2.60
18.39
14.8
4.7
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
59
173
3.79
17.70
6.4
9.0
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
43
102
4.57
17.10
2.6
2.6
u/ml
0.4
0.4
0.01
32
54
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
19
20
9.89
16.22
1.1
1.3
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
14
11
13.12
14.32
1.5
1.5
e9/l
0.1
0.2
0.89
14
11
(3010813) Leukocytes [#/volume] in Blood
335
3874
0.41
12.49
40.3
18.1
e9/l
7.7
6.7
11.57
322
3749
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
24
45
5.59
12.43
2.3
5.8
iu/ml
128.2
136.0
—
6
6
(3024561) Albumin [Mass/volume] in Serum or Plasma
211
1359
2.07
12.41
5.5
3.7
g/l
33.8
35.8
5.93
203
1253
(3026361) Erythrocytes [#/volume] in Blood
335
3872
0.41
12.37
40.2
18.0
e12/l
4.4
4.6
9.78
322
3744
(3035941) MCH [Entitic mass]
335
3871
0.41
12.30
40.1
17.9
pg
31.0
30.5
6.89
330
3797
(3007461) Platelets [#/volume] in Blood
335
3869
0.42
12.18
40.4
18.0
e9/l
224.9
244.5
7.51
324
3752
(3019060) Gas panel - Arterial blood
60
224
2.95
12.12
6.2
4.9
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
247
3181
0.48
12.08
3.7
4.5
mu/l
1.8
2.3
0.85
220
2876
(3017181) Myelocytes/100 leukocytes in Blood
62
239
2.86
11.81
2.7
4.3
%
1.4
0.7
2.15
33
52
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
10
12.31
11.78
1.5
1.2
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
22
41
5.60
11.46
1.4
1.1
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
69
291
2.63
11.04
1.8
1.7
nmol/l
286.0
359.0
2.23
61
267
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
22
43
5.34
10.90
1.3
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
19
33
5.97
10.62
1.4
1.0
—
—
—
0
0
(3000991) Gas panel - Venous blood
65
273
2.62
10.47
4.1
7.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
119
1903
0.48
10.23
2.5
2.6
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
68
1332
0.42
10.08
2.4
2.6
ug/l
204.5
140.0
0.89
57
1211
(1761868) Lipid panel - Serum or Plasma
62
1261
0.41
10.08
2.4
3.1
—
—
—
0
0
(3018418) pH of Serum or Plasma
151
922
1.98
9.76
3.4
3.1
ph
7.4
7.4
0.05
27
145
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
188
2575
0.52
9.75
3.4
3.6
pmol/l
14.7
14.9
0.52
170
2310
(3002179) Metamyelocytes/100 leukocytes in Blood
54
214
2.74
9.73
2.6
4.4
%
0.4
0.2
0.74
19
40
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
42
145
3.10
9.69
2.0
2.3
ug/l
110.1
335.6
3.44
42
133
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
17
30
5.86
9.34
1.2
1.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
58
1180
0.41
9.26
2.8
3.2
mg/l
42.1
196.7
1.12
36
751
(3026008) Bacteria identified in Urine by Culture
146
911
1.91
8.68
2.4
3.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
13
560
0.21
8.64
1.1
1.3
u/ml
1.1
8.6
—
5
202
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
74
1335
0.46
8.47
1.7
2.2
nmol/l
75.8
78.3
0.32
68
1170
(3020682) Albumin/Creatinine [Ratio] in Urine
67
1246
0.45
8.30
3.2
3.8
mg/mmol
11.6
7.3
0.34
34
790
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
57
1123
0.43
8.20
1.8
2.9
ng/l
461.2
1331.4
6.94
50
947
(3009508) Creatinine [Moles/volume] in Urine
65
1218
0.45
8.19
2.5
3.0
mmol/l
9.4
7.9
0.96
53
1009
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
10
11
9.28
8.11
1.2
1.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
11
14
8.04
8.02
1.3
1.1
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
11
6
18.76
7.63
1.2
1.8
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
147
959
1.80
7.38
2.5
3.0
e6/l
26.5
117.8
0.73
120
732
(3013707) Erythrocyte sedimentation rate by Westergren method
197
2567
0.57
7.36
2.7
4.1
mm/h
12.2
11.7
0.16
176
2345
(3026493) Urate [Moles/volume] in Serum or Plasma
45
938
0.42
7.32
2.2
2.4
umol/l
11045.6
7526.5
0.13
37
808
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
101
591
1.92
7.11
4.0
2.1
mmol/l
2.4
2.4
0.55
90
498
(3021960) Folate [Moles/volume] in Serum or Plasma
39
853
0.40
7.10
1.3
1.5
nmol/l
19.1
21.2
0.58
34
725
(3020564) Creatinine [Moles/volume] in Serum or Plasma
330
3726
0.53
7.05
32.2
14.4
umol/l
68.8
80.0
22.54
330
3726
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
116
712
1.86
7.05
3.1
3.7
ng/l
50.9
377.4
2.70
90
573
(21494815) CD4 cells/100 lymphocytes in Specimen
12
20
6.14
6.94
1.3
1.6
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
11
8
14.06
6.92
1.2
1.6
%
5.8
4.6
—
11
8
(21494814) CD8 cells/100 lymphocytes in Specimen
11
8
14.06
6.92
1.2
1.6
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
135
875
1.79
6.84
2.3
2.9
e6/l
0.5
0.5
0.02
111
645
(3012501) Base excess in Blood by calculation
21
59
3.69
6.67
2.3
3.1
mmol/l
2.7
2.7
0.03
14
37
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
89
513
1.92
6.52
1.9
1.8
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
94
1471
0.54
6.52
1.7
2.0
pmol/l
93.4
95.7
0.22
48
743
(40761511) CBC panel - Blood by Automated count
319
3620
0.55
6.44
23.1
11.7
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
49
229
2.28
6.23
2.9
4.4
%
0.2
0.1
0.68
31
47
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
102
1541
0.56
6.16
3.1
3.7
ug/l
2.2
1.9
0.33
84
1370
(36304419) Bacteria [Presence] in Urine
129
848
1.74
6.13
2.4
2.8
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
13
27
4.93
6.01
1.8
1.9
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
194
1432
1.64
5.91
16.7
8.0
e9/l
0.0
0.0
1.59
158
1178
(3028679) Herpes simplex virus Ab [Presence] in Serum
10
9
11.34
5.82
1.1
1.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
76
1234
0.53
5.81
2.8
3.6
%
21.7
24.0
0.92
33
546
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
13
28
4.76
5.77
1.2
1.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
44
208
2.24
5.45
1.4
1.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
66
370
1.92
5.21
1.6
1.8
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
12
27
4.54
5.06
4.0
3.9
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
65
366
1.91
5.06
1.6
1.8
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
9
9
10.18
5.04
1.0
1.1
—
—
—
0
0
(3026782) Osmolality of Urine
96
613
1.73
4.95
2.1
2.5
mosm/kgh2o
568.1
545.7
0.47
86
503
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
158
1151
1.59
4.85
2.6
3.0
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
153
1111
1.58
4.74
2.7
3.6
e6/l
35.6
89.0
2.23
122
792
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
289
3300
0.63
4.71
26.2
11.3
ml/min/173m2
88.2
78.7
16.54
263
2652
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
82
514
1.73
4.50
2.0
2.9
e6/l
2.5
1.6
0.64
52
280
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
14
400
0.33
4.46
1.3
1.5
—
—
—
0
0
(4094501)
0
112
0.00
4.44
0.0
1.1
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
10
22
4.63
4.32
1.9
17.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
8
9
9.03
4.29
2.4
2.0
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
34
657
0.48
4.29
1.2
1.2
u/ml
0.5
1.5
—
7
179
(4010399)
9
285
0.30
4.26
1.0
1.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
18
62
2.99
4.22
1.4
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
18
62
2.99
4.22
1.4
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
43
761
0.52
4.16
3.3
3.7
kg/l
1.0
1.0
0.11
13
110
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
10
8.12
4.07
1.0
1.2
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
58
340
1.81
3.98
1.9
2.3
umol/l
4.8
7.5
2.71
53
293
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
8
11
7.38
3.87
1.3
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
8
11
7.38
3.87
1.3
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
8
11
7.38
3.87
1.3
1.2
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
11
7.38
3.87
1.3
1.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
88
1258
0.62
3.82
3.2
3.6
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
6
5
12.14
3.77
1.2
1.4
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
122
1615
0.66
3.67
2.9
3.5
estimate
0.0
0.0
0.00
24
260
(1616796) Gas panel - Central venous blood
16
57
2.88
3.56
1.6
2.8
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
6
6
10.12
3.50
1.0
1.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
124
1621
0.67
3.44
4.0
4.8
estimate
0.0
0.0
0.00
24
258
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
25
114
2.27
3.42
2.1
1.5
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
10
27
3.77
3.37
1.0
1.1
mg/l
48.8
37.2
—
10
22
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
55
858
0.59
3.36
2.2
2.6
ug/l
0.6
0.7
1.26
32
555
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
81
0.00
3.17
0.0
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
7
214
0.32
3.15
1.0
1.3
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
81
555
1.56
3.11
2.1
2.7
e6/l
1.7
1.0
0.45
50
319
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
48
760
0.59
3.09
1.3
1.7
pmol/l
492.7
15495642.4
0.79
38
626
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
6
8
7.58
3.06
1.5
1.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
58
873
0.61
3.05
3.3
3.7
estimate
0.0
0.0
0.50
21
254
(3009261) Glucose [Presence] in Urine by Test strip
129
1644
0.69
3.01
3.0
3.5
estimate
0.0
0.0
0.50
23
252
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
5
5
10.09
2.98
1.0
6.4
%
202.8
87.4
—
5
5
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
5
10.09
2.98
1.2
1.0
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
95
686
1.49
2.86
6.1
4.3
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
21
417
0.48
2.85
1.6
2.3
%
25.3
24.4
0.10
15
358
(3025159) Blasts/100 leukocytes in Blood
38
219
1.81
2.79
3.1
4.5
%
0.0
2.1
0.48
21
42
(40768797) Stomach Pathology biopsy report
25
464
0.51
2.78
1.0
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
32
175
1.89
2.76
2.2
1.4
ug/l
3.7
4.4
0.16
20
135
(21494755) Public health laboratory ask at order entry panel
11
278
0.38
2.74
1.2
1.4
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
7
14
5.06
2.74
1.3
1.1
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
91
659
1.48
2.69
2.4
2.2
e6/l
6.8
5.0
0.53
84
564
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
55
811
0.63
2.62
1.4
2.1
mg/l
3.0
3.0
0.01
42
677
(3022806) Fractional oxyhemoglobin in Capillary blood
11
38
2.94
2.60
2.0
1.7
%
88.2
90.4
0.53
11
38
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
16
69
2.37
2.51
1.1
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
14
304
0.44
2.44
1.4
1.9
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
5
8
6.31
2.38
1.0
3.1
%
126.0
94.8
—
5
8
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
27
465
0.55
2.36
1.1
1.4
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
10
35
2.90
2.32
1.1
1.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
55
790
0.65
2.31
2.5
3.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
15
66
2.32
2.27
1.3
1.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
170
1409
1.34
2.26
3.5
3.6
ng/l
18.1
43.3
5.16
144
1032
(3005322) IgE [Units/volume] in Serum or Plasma
8
199
0.39
2.22
1.0
1.3
u/ml
90.1
234.9
—
8
181
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
55
2.41
2.14
1.2
1.2
—
—
—
0
0
(3019225) pH of Specimen
49
327
1.56
2.13
3.2
3.3
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
23
401
0.55
2.11
1.3
1.9
%
1.3
1.6
2.11
16
346
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
8
25
3.24
2.10
1.0
1.0
—
—
—
0
0
(3000492) Spirometry study
17
322
0.51
2.04
1.4
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
14
63
2.26
2.03
1.2
1.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
30
480
0.60
2.01
8.8
6.8
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
48
329
1.52
1.87
3.8
2.9
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
82
1055
0.73
1.86
2.2
2.2
u/l
52.3
57.4
1.32
76
968
(3051651) Icteric interference index of Serum or Plasma
6
17
3.56
1.84
3.8
2.8
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
29
2.79
1.80
1.0
1.1
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
47
326
1.50
1.74
2.2
3.3
mmol/l
2.1
2.2
0.06
42
268
(3009542) Hematocrit [Volume Fraction] of Blood
291
3147
0.77
1.73
30.8
13.3
%
39.3
40.6
1.63
204
2149
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
5
13
3.88
1.72
1.0
1.1
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
0
46
0.00
1.71
0.0
1.5
—
66.9
—
0
32
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
15
75
2.04
1.71
2.1
1.8
u/ml
13.4
81.9
—
10
57
(3051611) Lipemic interference index of Serum or Plasma
7
26
2.72
1.58
4.0
2.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
11
218
0.49
1.55
1.5
1.9
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
10
44
2.30
1.54
1.1
1.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
13
65
2.03
1.50
1.2
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
17
290
0.57
1.49
4.0
2.9
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
57
425
1.39
1.47
6.3
5.9
mmol/l
105.0
104.1
0.81
57
413
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
16
88
1.85
1.43
1.4
1.6
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
42
575
0.70
1.38
1.1
1.2
g/l
2.1
2.8
2.50
22
344
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
9
41
2.22
1.37
1.4
1.3
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
19
112
1.73
1.37
4.5
4.5
mmol/l
3.8
4.0
0.97
19
105
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
33
472
0.67
1.37
3.1
4.8
%
29.7
31.7
0.66
24
313
(4027681)
6
23
2.63
1.37
1.0
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
10
193
0.51
1.33
1.5
1.8
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
10
48
2.11
1.28
1.1
1.1
—
—
—
0
0
(44790047)
8
35
2.31
1.27
1.0
1.4
—
—
—
0
0
(44790049)
8
35
2.31
1.27
1.0
1.4
—
—
—
0
0
(44790048)
8
35
2.31
1.27
1.0
1.4
—
—
—
0
0
(44806118)
8
35
2.31
1.27
1.0
1.4
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
8
36
2.24
1.25
1.4
1.4
promille
0.4
1.4
—
8
31
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
20
124
1.64
1.23
2.5
1.6
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
19
2.65
1.22
1.2
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
22
331
0.65
1.19
1.0
1.3
—
—
—
0
0
(4034850)
6
127
0.47
1.18
9.5
11.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
247
2265
1.21
1.17
4.1
4.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
13
72
1.83
1.16
1.1
1.2
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
5
20
2.52
1.15
2.8
2.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
15
88
1.73
1.12
4.4
3.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
14
231
0.59
1.12
1.0
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
69
848
0.78
1.12
2.9
3.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
5
22
2.29
1.03
2.8
2.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
5
22
2.29
1.03
1.4
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
9
47
1.93
1.02
1.4
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
7
132
0.52
1.00
1.0
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
7
35
2.02
1.00
1.4
1.1
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
5
23
2.19
0.98
1.0
1.1
mmol/l
35.9
33.3
—
5
23
(3028707) Methadone [Presence] in Urine by Screen method
7
36
1.96
0.97
1.0
1.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
9
50
1.82
0.97
2.7
2.5
e9/l
6.5
4.7
—
9
50
(3044889) 12 lead EKG panel
235
2529
0.85
0.97
3.1
4.0
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
0
31
0.00
0.96
0.0
1.3
—
61.8
—
0
6
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
9
51
1.78
0.95
3.0
3.0
%
68.0
58.7
—
9
51
(1002224) Polysomnography panel
8
146
0.54
0.94
1.0
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
8
138
0.57
0.84
1.0
1.0
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
8
45
1.79
0.84
1.1
1.8
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
6
112
0.53
0.84
2.0
1.6
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
11
65
1.71
0.83
1.3
1.8
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
15
222
0.66
0.79
1.1
1.2
—
—
—
0
0
(3036603) Volume of Urine
0
24
0.00
0.79
0.0
1.6
—
1980.7
—
0
6
(3023430) Cat dander IgE Ab [Units/volume] in Serum
0
24
0.00
0.79
0.0
1.1
—
5.9
—
0
8
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
6
33
1.83
0.79
1.5
1.6
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
8
48
1.68
0.79
4.3
2.1
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
0
26
0.00
0.78
0.0
1.8
—
25.3
—
0
6
(3014133) Dog dander IgE Ab [Units/volume] in Serum
0
26
0.00
0.78
0.0
1.1
—
5.0
—
0
8
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
0
27
0.00
0.77
0.0
1.3
—
1.5
—
0
17
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
331
3438
0.84
0.77
27.8
12.2
mg/l
16.4
23.4
8.57
320
2622
(3025941) Bacteria identified in Stool by Culture
10
161
0.61
0.77
1.7
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
8
134
0.59
0.74
3.0
1.9
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
19
134
1.44
0.72
4.5
4.0
mmol/l
1.7
1.4
0.86
19
129
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
7
41
1.72
0.70
1.3
1.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
12
77
1.57
0.69
1.2
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
27
349
0.76
0.67
1.2
1.4
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
56
661
0.82
0.66
1.6
1.8
nmol/l
934.8
1196.5
2.23
41
497
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
7
44
1.60
0.65
1.6
1.5
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
8
49
1.64
0.62
4.3
2.1
mmol/l
4.0
4.0
—
8
49
(3035285) Chloride [Moles/volume] in Venous blood
8
49
1.64
0.62
4.3
2.1
mmol/l
102.5
105.8
—
8
49
(3017704) Immunofixation for Urine
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
21
0.00
0.60
0.0
1.7
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
23
0.00
0.58
0.0
1.5
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
0
23
0.00
0.58
0.0
9.1
—
38.6
—
0
10
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
5
87
0.57
0.56
1.2
1.2
—
1.2
—
0
5
(3023520) Reticulocytes [#/volume] in Blood
22
283
0.77
0.55
1.9
2.1
e9/l
66.3
65.0
0.07
15
226
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
13
91
1.44
0.53
1.7
2.4
%
118.0
88.7
2.65
13
86
(3022217) INR in Platelet poor plasma by Coagulation assay
58
502
1.18
0.52
9.4
24.4
inr
1.2
1.3
0.44
18
73
(3021879) Hepatitis B virus core Ab [Presence] in Serum
13
179
0.72
0.51
1.0
1.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
27
216
1.27
0.51
3.4
2.8
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
10
67
1.50
0.50
1.2
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
13
93
1.41
0.48
3.1
4.4
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
5
81
0.61
0.46
1.2
1.2
—
2.8
—
0
15
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
5
82
0.61
0.46
1.2
1.2
—
4.1
—
0
15
(3049717) Cytology report of Urine Cyto stain
8
120
0.66
0.46
2.1
1.7
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
22
174
1.28
0.46
2.9
2.7
e6/l
1.1
0.2
0.52
22
168
(3011288) Drugs identified in Urine by Screen method
7
51
1.38
0.44
1.0
1.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
45
388
1.18
0.43
1.7
1.6
—
—
—
0
0
(21494434) Karyotype in Bone marrow
5
31
1.62
0.43
1.0
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
31
1.62
0.43
1.4
1.7
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
20
249
0.79
0.41
1.8
1.9
g/l
0.3
0.2
3.01
20
220
(3036670) Protein [Mass/volume] in Synovial fluid
0
15
0.00
0.41
0.0
1.1
—
39.8
—
0
10
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(4015189)
0
15
0.00
0.41
0.0
2.9
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
15
114
1.33
0.41
1.5
3.6
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
1.2
—
207.4
—
0
17
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
11.5
—
971.6
—
0
17
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
13.0
—
1639.6
—
0
17
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
8
60
1.34
0.40
1.5
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
0
19
0.00
0.39
0.0
1.4
—
13.3
—
0
7
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
30
252
1.20
0.39
2.3
2.6
—
20.8
—
0
9
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
27
225
1.21
0.38
1.3
1.4
—
49.3
—
0
12
(3015171) Extractable nuclear Ab [Units/volume] in Serum
8
114
0.70
0.37
1.3
1.2
—
0.3
—
0
7
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
15
191
0.78
0.37
1.2
1.2
iu/ml
122.3
111.0
—
5
80
(4268621)
5
37
1.36
0.37
1.8
2.4
—
—
—
0
0
(3002256) Pathology report gross observation
29
245
1.20
0.36
1.1
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
5
77
0.65
0.36
1.2
1.4
—
—
—
0
0
(3020891) Body temperature
18
144
1.26
0.36
5.1
4.7
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
37
425
0.86
0.35
1.4
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
45
1.34
0.34
1.7
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
20
164
1.23
0.33
2.0
3.7
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
7
96
0.72
0.31
1.6
1.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
28
324
0.85
0.30
1.1
1.4
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
22
185
1.20
0.29
2.3
2.3
%
1.2
1.3
0.14
22
185
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
23
195
1.19
0.29
1.4
1.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
10
76
1.32
0.28
1.3
1.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
8
63
1.27
0.28
1.0
1.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
69
741
0.92
0.24
1.6
1.7
mg/l
3.6
1.1
1.50
58
567
(3016879) Cocaine [Presence] in Urine
10
79
1.27
0.22
1.0
1.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
5
41
1.22
0.22
1.0
2.7
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
0
11
0.00
0.21
0.0
7.2
—
26.6
—
0
11
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
11
0.00
0.21
0.0
1.2
—
9.6
—
0
11
(3036071) Salmonella sp Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
10
0.00
0.21
0.0
7.7
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
10
0.00
0.21
0.0
7.7
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
12
0.00
0.21
0.0
1.1
—
1.2
—
0
12
(21491868) Cryoglobulin [Mass/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.5
—
17.0
—
0
12
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
17
198
0.85
0.21
2.0
2.3
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
0.4
—
0
6
(3013637) Mi-2 Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
13
0.00
0.21
0.0
3.5
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
13
0.00
0.21
0.0
3.5
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
6
48
1.25
0.20
1.0
1.1
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
6
50
1.20
0.20
1.2
2.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
10
81
1.24
0.19
1.0
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
6
53
1.13
0.18
1.0
1.2
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
7
58
1.21
0.18
1.4
1.3
iu/l
18.3
24.6
—
7
52
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
16
138
1.17
0.17
2.2
4.1
mmol/l
25.1
25.1
0.02
16
127
(3021901) Oxygen saturation in Capillary blood
7
61
1.15
0.17
1.0
2.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
5
69
0.72
0.17
1.0
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
10
83
1.21
0.15
1.0
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
10
83
1.21
0.15
1.0
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
9
81
1.11
0.15
1.0
1.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
21
188
1.12
0.15
1.1
1.5
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
7
88
0.79
0.14
1.4
2.6
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
7
89
0.78
0.14
1.1
2.1
mg/l
11.2
11.8
—
7
84
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
7
90
0.77
0.14
1.3
1.3
—
1.1
—
0
12
(3014765) Yersinia sp identified in Stool by Organism specific culture
8
96
0.83
0.14
1.5
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
8
97
0.82
0.14
1.5
1.1
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
11
127
0.86
0.12
1.2
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
13
147
0.88
0.11
1.5
1.2
—
—
—
0
0
(4306422)
5
47
1.06
0.09
1.0
1.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
5
47
1.06
0.09
1.0
1.0
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
6
54
1.11
0.09
1.3
1.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
225
2278
0.97
0.08
4.2
3.0
u/l
78.7
48.8
1.19
217
2115
(3014051) Protein [Presence] in Urine by Test strip
6
74
0.81
0.07
3.5
2.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
7
82
0.85
0.07
1.9
1.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
17
158
1.08
0.06
1.1
1.6
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
37
383
0.96
0.04
1.8
2.0
%
1.9
1.7
0.42
30
335
(3042936) Bacteria identified in Isolate by Culture
47
483
0.97
0.04
1.5
1.9
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
27
279
0.97
0.02
6.1
2.1
ml/min/173m2
73.8
63.6
0.73
12
112
(3004588) Protein electrophoresis panel - Serum or Plasma
21
218
0.96
0.02
1.1
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
29
298
0.97
0.02
1.1
1.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
42
412
1.02
0.01
1.2
1.6
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
18
177
1.02
0.00
4.1
3.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
25
252
0.99
0.00
3.1
3.4
—
—
—
0
0
(3013512) EKG study
108
1081
1.00
0.00
3.6
3.9
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
37
366
1.01
0.00
1.4
2.5
ug/l
2.5
7.6
5.64
30
322
(3009214) Lutropin [Units/volume] in Serum or Plasma
6
69
0.87
0.00
1.0
1.4
u/l
5.3
7.9
—
6
57
(3024471) HLA-A [Type]
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
9
0.00
0.00
0.0
2.9
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
2.9
—
0
7
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
1.9
—
0
5
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055442) Apixaban [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
68.8
—
0
5
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
6
66
0.91
0.00
1.3
1.2
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
16.3
—
0
7
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
3.1
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
5
51
0.98
0.00
1.0
1.2
mmol/l
7.0
7.7
—
5
35
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
7
79
0.88
0.00
1.0
1.4
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
5
56
0.89
0.00
1.2
1.0
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
0
8
0.00
0.00
0.0
5.3
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
6
0.00
0.00
0.0
5.2
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
9
0.00
0.00
0.0
8.4
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
7
0.00
0.00
0.0
6.6
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.5
—
105.2
—
0
8
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_GBM_EXALLC – Brain glioblastoma, excluding all cancers (controls excluding all cancers)
GWS hits: 3
This endpoint is excluded (different definition than used in FinnGen).